Video
  • Featured content
    HoChong Gilles, RN, MS, FNP, and April G. Long, RN, MS, FNP, provide practical strategies and suggestions to assist providers with improving outcomes for their patients receiving HCV therapy. Ten individual recommendations developed from the faculty’s experiences cover subjects from adherence to managing adverse events and patient expectations and relevant literature.
  • Featured content
    This interactive video module provides a wealth of practical strategies for overcoming challenges associated with direct-acting antiviral therapies for HCV, including input from real patient experiences and expert guidance from a multidisciplinary expert faculty.
  • Featured content
  • Featured content
    Fred Poordad, MD, provides his perspectives on how the introduction of targeted therapies may impact patient care and the steps that clinicians and medical centers may consider taking to better prepare them for the changing treatment paradigm.
    Date Posted: 5/6/2010
  • Featured content
    Nezam H. Afdhal, MD, FRCPI; Steven Flamm, MD; and Fred Poordad, MD, review the clinical implications of the latest diagnostic, prognostic, and treatment data pertaining to patients infected with hepatitis C virus.

    In this edition of Stay Tuned Hepatitis, Nezam H. Afdhal, MD, FRCPI, provides insight into the clinical utility of new prognostic and diagnostic tools for hepatitis C; Steven Flamm, MD, reviews strategies for managing mild liver disease in the setting of HCV in 2010; and Fred Poordad, MD, highlights the likely impact of new HCV therapies on current practices in the clinic.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Video

10 of 13 Shown
10 of 13 Shown
Show 3 More
Loading...